Patents Assigned to LIMITED LIABILITY COMPANY “PHARMENTERPRISES”
  • Chemical compounds (derivatives) and their application for the treatment of oncological diseases
    Patent number: 9695182
    Abstract: Compounds of formula I, in which LA, LB, LC, ring A, ring B, RA, RB, RC, RD, RE and RF are defined in the description, and which are protein kinases inhibitors. The invention also relates to pharmaceutical compositions containing said compounds and also to the use of those compounds for treatment and/or prevention of diseases related with aberrant protein kinase activity.
    Type: Grant
    Filed: June 30, 2014
    Date of Patent: July 4, 2017
    Assignees: LIMITED LIABILITY COMPANY “NATIONAL PHARMACEUTICAL TECHNOLOGIES”, LIMITED LIABILITY COMPANY “PHARMENTERPRISES”
    Inventors: Germes Grigorievich Chilov, Oleg Valentinovich Stroganov, Viktor Sergeevich Stroilov, Fedor Nikolaevich Novikov, Aleksey Alexandrovich Zeifman, Ilya Yurievich Titov